Use Of Capnography As Surrogate Measure Of PC02 In Medical Intensive Care Unit (ICU) Patients
NCT ID: NCT00744614
Last Updated: 2010-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
70 participants
OBSERVATIONAL
2007-11-30
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Medical Intensive care unit patients with asthma, COPD, ILD or coronary disease who are at risk of intubation
Capnography
A technique for monitoring the concentration or partial pressure of CO2 levels in respiratory gases
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Capnography
A technique for monitoring the concentration or partial pressure of CO2 levels in respiratory gases
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Not intubated
* Age 18 or older
* History of any one of the following: asthma, COPD, ILD, or coronary disease
Exclusion Criteria
* Life expectancy less than 1 month
* Requiring BIPAP
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lahey Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lahey Clinic, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David R. Riker, M.D.
Role: PRINCIPAL_INVESTIGATOR
Lahey Clinic, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lahey Clinic, Inc.
Burlington, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Torok SS, Leuppi JD, Baty F, Tamm M, Chhajed PN. Combined oximetry-cutaneous capnography in patients assessed for long-term oxygen therapy. Chest. 2008 Jun;133(6):1421-1425. doi: 10.1378/chest.07-0960. Epub 2008 Mar 13.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-115
Identifier Type: -
Identifier Source: org_study_id